Immunologik

Developer of novel antiviral drug candidates targeting host cell structures

placeBerlin, Berlin, Germany calendar_todayFounded 2012 groups2 employees language immunologik.de

Innovation

6 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 237 times.

YearFilings
20163
20172
20181
20201
20213
20223
20232
20251

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon